A combination of two drugs, which prompt the body's immune system to identify and kill cancer cells, is a safe treatment for patients with advanced non-small cell lung cancer and has shown some signs of efficacy.
Scientists have made a major discovery that shines a new, explanatory light on the link between obesity and cancer. Their research confirms why the body's immune surveillance systems—led by cancer-fighting Natural Killer cells—stutter and fail in the presence of excess fat.
A triple therapy combining two immune checkpoint inhibitors (ICPIs) with the standard-of-care chemotherapy, a hypomethylating agent called azacitidine, has shown promising results for treatment of relapsed or refractory acute myeloid leukemia (AML), according to findings from a Phase II study at The University of Texas MD Anderson Cancer Center.
In one of the largest studies to measure the burden of antibiotic resistance in a low- or middle-income country, researchers at the Center for Disease Dynamics, Economics & Policy report that in-hospital mortality is significantly higher among patients infected with multi-drug resistant (MDR) or extensively drug resistant (XDR) pathogens including Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
While microbial communities are the engines driving the breakdown of dead plants and animals, little is known about whether they are equipped to handle big changes in climate. In a new study, researchers examine what happens after microbial communities move into new climate conditions. The study is a first step toward understanding the vulnerability of these ecosystems to climate change.
"Healthy aging" sounds like a priority we all can share, but for geriatrics healthcare professionals the doctors, nurses, pharmacists, physicians assistants, social workers, and many others dedicated to the care we need as we age that term represents something specific, and something worth defining.
The new European Organ-on-Chip Society (EUROoCS) was officially launched at the third International Organ-on-Chip Symposium, held on 8 and 9 November 2018 at the University of Technology in Eindhoven, the Netherlands.
The Society will encourage development and coordination of Organ-on-Chip research in Europe in support of better health for all. Membership will be open from 2019 to all researchers in the field, providing access benefits to the pending digital Organ-on-Chip platform, the annual meeting and the future society journal.
Treating appendicitis with antibiotics as an alternative to surgical removal of the inflamed organ was found to be more costly in the long term and result in higher rates of hospital readmissions, according to a study by researchers at the Stanford University School of Medicine.
When healthy people eat a low-gluten and fibre-rich diet compared with a high-gluten diet, they experience less intestinal discomfort including less bloating. Researchers at University of Copenhagen show that this is due to changes of the composition and function of gut bacteria.
Scientists from the University of Sheffield have discovered a new inhibitor which decreases lung inflammation and could hold the key to treating Acute Respiratory Distress Syndrome – a life-threatening disease which affects thousands of people in the UK.
A team of researchers at the University of Cincinnati (UC) College of Medicine have been awarded $3.4 million by the National Institutes of Health (NIH) to study the role of the gastrointestinal (GI) lymphatic system in dietary nutrient absorption and the transport of signaling molecules.
Research is an important component of academic medicine, but many family medicine departments have struggled with barriers ranging from departmental culture to the lack of resources needed to advance the field.